Related Articles
Decline in serum progastrin‑releasing peptide predicts the response of patients with small cell lung cancer to chemotherapy
Association between serum tumor markers and metabolic tumor volume or total lesion glycolysis in patients with recurrent small cell lung cancer
Evaluation of the soluble fragments of cytokeratin 19 (CK19) in non-small cell lung cancer (NSCLC)
Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib
TNP-ALPHA DETERMINATION IN SERUM AND PLEURAL EFFUSION IN PATIENTS WITH LUNG-CANCER